Portal de Periódicos da CAPES

242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder

2007; Lippincott Williams & Wilkins; Volume: 177; Issue: 4S Linguagem: Inglês

10.1016/s0022-5347(18)30507-x

1527-3792

Fabrizio Verweij, V. Matei, E. Scardino, Bernardo Rocco, Gennaro Musi, Umberto Besana, S. Zambito, Marcelo Pimentel, Eduardo Pedroso, Ottavio De Cobelli, Filippo de Braud, Giuseppe Curigliano, Gianluca Spitaleri, Salvatore Pece, Romano Danesi, Valentina Mey, Elisa Giovanetti, Sara Nanizzi,

Esophageal Cancer Research and Treatment

You have accessJournal of UrologyPodium 7, Sunday, May 20, 2007, 8:00 - 10:00 am1 Apr 2007242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder Fabrizio Verweij, Victor D. Matei, Epifanio Scardino, Bernardo Rocco, Gennaro Musi, Umberto Besana, Stefano Zambito, Marcelo Pimentel, Eduardo Pedroso, Ottavio de Cobelli, Filippo de Braud, Giuseppe Curigliano, Gianluca Spitaleri, Salvatore Pece, Romano Danesi, Valentina Mey, Elisa Giovanetti, and Sara Nanizzi Fabrizio VerweijFabrizio Verweij More articles by this author , Victor D. MateiVictor D. Matei More articles by this author , Epifanio ScardinoEpifanio Scardino More articles by this author , Bernardo RoccoBernardo Rocco More articles by this author , Gennaro MusiGennaro Musi More articles by this author , Umberto BesanaUmberto Besana More articles by this author , Stefano ZambitoStefano Zambito More articles by this author , Marcelo PimentelMarcelo Pimentel More articles by this author , Eduardo PedrosoEduardo Pedroso More articles by this author , Ottavio de CobelliOttavio de Cobelli More articles by this author , Filippo de BraudFilippo de Braud More articles by this author , Giuseppe CuriglianoGiuseppe Curigliano More articles by this author , Gianluca SpitaleriGianluca Spitaleri More articles by this author , Salvatore PeceSalvatore Pece More articles by this author , Romano DanesiRomano Danesi More articles by this author , Valentina MeyValentina Mey More articles by this author , Elisa GiovanettiElisa Giovanetti More articles by this author , and Sara NanizziSara Nanizzi More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)30507-XAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder." The Journal of Urology, 177(4S), p. 81 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 177Issue 4SApril 2007Page: 81 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Fabrizio Verweij More articles by this author Victor D. Matei More articles by this author Epifanio Scardino More articles by this author Bernardo Rocco More articles by this author Gennaro Musi More articles by this author Umberto Besana More articles by this author Stefano Zambito More articles by this author Marcelo Pimentel More articles by this author Eduardo Pedroso More articles by this author Ottavio de Cobelli More articles by this author Filippo de Braud More articles by this author Giuseppe Curigliano More articles by this author Gianluca Spitaleri More articles by this author Salvatore Pece More articles by this author Romano Danesi More articles by this author Valentina Mey More articles by this author Elisa Giovanetti More articles by this author Sara Nanizzi More articles by this author Expand All Advertisement PDF downloadLoading ...